We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Frost & Sullivan today announced the results of a research study that points the way for biosimilar companies to take market share from blockbuster drugs, and for pharmaceutical companies with blockbusters to protect their position